2020
DOI: 10.3390/ijerph17020440
|View full text |Cite
|
Sign up to set email alerts
|

Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany

Abstract: Around 1% of the world’s population is infected with hepatitis C. The introduction of new direct-acting antiviral agents (DAAs) in 2014 has substantially improved hepatitis C treatment outcomes. Our objective was to evaluate the long-term cost effectiveness of DAAs in health care personnel (HP) with confirmed occupational diseases in Germany. A standardised database from a German statutory accident insurance was used to analyse the cost-effectiveness ratio for the DAA regimen in comparison with interferon-base… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 47 publications
(56 reference statements)
0
2
0
Order By: Relevance
“…This effect becomes more pronounced the earlier an HCV infection is diagnosed and treated. Taking pension benefits into account, use of DAA treatments in insured HP without cirrhosis correlates with a reduction in costs [5]. Costeffectiveness models also show that early treatment is more cost-efficient than treatment at a later stage of the disease [15].…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…This effect becomes more pronounced the earlier an HCV infection is diagnosed and treated. Taking pension benefits into account, use of DAA treatments in insured HP without cirrhosis correlates with a reduction in costs [5]. Costeffectiveness models also show that early treatment is more cost-efficient than treatment at a later stage of the disease [15].…”
Section: Discussionmentioning
confidence: 98%
“…This regimen achieves highly sustained virological responses (SVRs) of over 95% with high compatibility [1]. Although DAA regimens are more effective, they are more costly than interferon-based treatments due to the expensive drugs involved [5]. Healthcare personnel (HP) work in environments with specific accident and disease risks.…”
Section: Introductionmentioning
confidence: 99%